Clinical trials in Kristianstad

Groundbreaking studies focusing on EGFR-mutated non-small cell lung cancer and triple negative breast cancer, evaluating innovative treatment sequences and combination therapies.

• EGFR inhibitor optimization studies
• Carboplatin-based therapy evaluation

Research aims to improve treatment outcomes for patients with advanced cancers.

Investigating treatments for acute ischemic stroke and giant cell arteritis, with innovative approaches using established medications in new applications.

• Stroke treatment optimization
• Arteritis management protocols
• Beta-blocker effectiveness studies

Focused on improving patient outcomes in critical cardiovascular conditions.

Studies addressing chronic obstructive pulmonary disease and diabetes management, including innovative treatments for diabetic foot ulcers.

• COPD exacerbation prevention
• Type 1 diabetes interventions
• Wound healing optimization

Advancing therapeutic approaches for long-term condition management.

Clinical trials examining treatments for bacterial infections and antibiotic resistance, including studies on urinary tract infections and bacteremia.

• Antibiotic efficacy studies
• Multi-drug resistant infection management

Developing solutions for challenging infectious conditions.

Research focusing on inflammatory bowel diseases, including studies on treatment optimization for Crohn's disease and ulcerative colitis.

• Anti-TNF therapy evaluation
• Remission maintenance strategies

Advancing understanding of autoimmune condition management.